| Helix Biopharma Cp (HXBPF) |
|
|
| OTC PK:HXBPF |
Last Trade: Tuesday, July 20, 2010 @ 8:10:11 PM |
| Last Price: 2.2222 |
Change: ($0.00 0.0%) |
| Open: |
0.00 |
Prev. Close: |
2.2222 |
| Day's High: |
2.2222 |
Low: |
2.2222 |
| 52-Week High: |
2.0975 |
52-Week Low: |
1.003 |
| Bid: |
0.00 / 0 |
Ask: |
0.00 / 0 |
| Volume: |
0 |
Outstanding: |
46,375,335 |
| Market cap: |
$85 M
|
|
|
|
|
| Helix BioPharma Corp., an integrated biopharmaceutical company, focuses on the discovery and development of anti-cancer therapeutics. The company leverages its proprietary technologies to identify new drug candidates and formulate novel drug products. Helix’ product development pipeline includes prospective therapeutics for the prevention of cancer through the elimination of a predisposing viral condition. Also, the company is exploring the biological mechanisms of cancer development, and pursuing the development of novel pharmaceuticals to block or reverse these processes. Helix commercializes the new drug products that arise from its development activities through strategic partnerships with sales and marketing companies. The company also seeks to develop strategic alliances to assist in co-developing its emerging therapeutics. |
Helix Biopharma Cp Press ReleasesHelix BioPharma Corp. Announces Positive Phase II Pharmacokinetic Findings for Topical Interferon Al - Thursday, June 24, 2010
Helix BioPharma Corp. Announces Fiscal Q3 2010 Results - Friday, June 11, 2010
Helix BioPharma Corp Announces Phase II Clinical Trial Results of Topical Interferon Alpha-2b in Pat - Wednesday, June 09, 2010
Helix BioPharma to Present at the BioFinance 2010 Conference on April 7 - Monday, April 05, 2010
Helix BioPharma Corp Achieves Last-Patient-Out in Its Phase II Trial of Topical Interferon Alpha-2b - Monday, March 22, 2010
Helix BioPharma Corp. Announces Fiscal Q2 2010 Results - Wednesday, March 10, 2010
Helix BioPharma To Present at Biotech Showcase(TM) 2010 on January 13 - Thursday, January 07, 2010
Helix BioPharma Corp. Announces Fiscal Q1 2010 Results - Wednesday, December 09, 2009
Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in P - Thursday, November 05, 2009
Helix BioPharma Corp. Announces Fiscal 2009 Results - Friday, October 30, 2009
Helix BioPharma Closes Private Placement - Tuesday, September 08, 2009
Helix BioPharma Announces $13.5 Million Private Placement - Friday, September 04, 2009
Get this stock quote and other market data from XML Stock Quotes.com
|
